Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.69% | 70.53% | -595.27% | -59.78% | 71.13% |
| Total Depreciation and Amortization | -- | -- | 0.00% | 0.00% | -69.54% |
| Total Amortization of Deferred Charges | -- | -- | 11.46% | -- | -- |
| Total Other Non-Cash Items | -100.00% | -99.60% | 1,586.61% | 74.29% | -276.36% |
| Change in Net Operating Assets | -52.16% | -121.61% | 82.25% | 3.06% | -28.22% |
| Cash from Operations | 14.00% | -44.46% | 1.57% | -45.50% | -785.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -200.00% |
| Total Debt Repaid | 100.00% | -111.25% | 51.88% | -70.00% | -- |
| Issuance of Common Stock | -92.18% | -56.38% | 1,582.61% | -94.04% | 2,658.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.56% | -63.68% | 3,433.50% | -103.03% | 1,834.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.99% | -132.20% | 244.41% | -159.05% | 3,395.68% |